1. Home
  2. PCVX vs MKSI Comparison

PCVX vs MKSI Comparison

Compare PCVX & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • MKSI
  • Stock Information
  • Founded
  • PCVX 2013
  • MKSI 1961
  • Country
  • PCVX United States
  • MKSI United States
  • Employees
  • PCVX N/A
  • MKSI N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • MKSI Industrial Machinery/Components
  • Sector
  • PCVX Health Care
  • MKSI Industrials
  • Exchange
  • PCVX Nasdaq
  • MKSI Nasdaq
  • Market Cap
  • PCVX 4.4B
  • MKSI 5.0B
  • IPO Year
  • PCVX 2020
  • MKSI 1999
  • Fundamental
  • Price
  • PCVX $33.25
  • MKSI $104.66
  • Analyst Decision
  • PCVX Strong Buy
  • MKSI Buy
  • Analyst Count
  • PCVX 10
  • MKSI 11
  • Target Price
  • PCVX $136.50
  • MKSI $131.73
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • MKSI 943.2K
  • Earning Date
  • PCVX 08-05-2025
  • MKSI 08-06-2025
  • Dividend Yield
  • PCVX N/A
  • MKSI 0.84%
  • EPS Growth
  • PCVX N/A
  • MKSI N/A
  • EPS
  • PCVX N/A
  • MKSI 3.36
  • Revenue
  • PCVX N/A
  • MKSI $3,654,000,000.00
  • Revenue This Year
  • PCVX N/A
  • MKSI $7.00
  • Revenue Next Year
  • PCVX N/A
  • MKSI $6.70
  • P/E Ratio
  • PCVX N/A
  • MKSI $31.14
  • Revenue Growth
  • PCVX N/A
  • MKSI N/A
  • 52 Week Low
  • PCVX $27.66
  • MKSI $54.84
  • 52 Week High
  • PCVX $121.06
  • MKSI $147.40
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 45.61
  • MKSI 71.72
  • Support Level
  • PCVX $32.00
  • MKSI $97.16
  • Resistance Level
  • PCVX $34.63
  • MKSI $100.80
  • Average True Range (ATR)
  • PCVX 1.33
  • MKSI 3.03
  • MACD
  • PCVX -0.06
  • MKSI 0.73
  • Stochastic Oscillator
  • PCVX 33.67
  • MKSI 94.46

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About MKSI MKS Instruments Inc.

MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.

Share on Social Networks: